Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
52.10
-1.42 (-2.65%)
At close: Jun 12, 2026
Shanghai Rendu Biotechnology Company Description
Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products.
It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer.
The company was founded in 2007 and is based in Shanghai, China.
Shanghai Rendu Biotechnology Co., Ltd.
| Country | China |
| Founded | 2007 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 290 |
| CEO | Minghui Yu |
Contact Details
Address: Zhangjiang High Tech Park Shanghai, 201201 China | |
| Phone | 86 21 5072 0200 |
| Website | rdbio.com |
Stock Details
| Ticker Symbol | 688193 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000059K5 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Jinliang Ju | Chairman of the Board and Chief Scientist |
| Minghui Yu | GM and Director |
| Tingjiang Cai | Accounting Officer, Accounting Supervisor, Chief Financial Officer and Secretary |
| Ruohua Cao | Deputy GM and Director |
| Zhenling Cui | Senior Director of Research & Development |
| Chang E Zhang | Registration Director and Director of Manufacturing Center |